Back to search
FDAFDA · Food and drugs·Recall number D-0436-2023

Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.

Published March 15, 2023 · Recall initiated: January 27, 2023

Summary

FDA records drug Class II recall D-0436-2023, published March 15, 2023 and initiated January 27, 2023. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 422 cartons; Lot: Lot 1009065, Exp 12/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot 1009065, Exp 12/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11. recalled?

Yes. FDA published recall D-0436-2023 on March 15, 2023. Reported hazard: Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

What should I do if I have this product?

Voluntary: Firm initiated · Letter